The company
Xenetic Biosciences, Inc.
XBIO · Nasdaq
XBIO stood above a rising 150-day average in 14 of the last 52 weekly readings, and has been out of that trend for the last 6 weeks. It is 32.8% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 6
- Industry in uptrend
- 18% -12 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 7 (+2)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 14 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026 | 117,440$342K | -20,000−14.6% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 17,423$51K | -4,018−18.7% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 12,681$37K | +5,950+88.4% |
| SBI Securities Co., Ltd.new · filed 23 Jul 2026 | 1,000$2,910 | +1,000 |
| Tower Research Capital LLC (TRC)reduced · filed 11 Aug 2026 | 696$2,025 | -110−13.6% |
| MORGAN STANLEYnew · filed 13 Aug 2026 | 150$437 | +150 |
| Darwin Wealth Management, LLCunchanged · filed 21 Jul 2026 | 2$5 | 00.0% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.